Skip to content
Search

Latest Stories

Stomach bug may increase risk of Alzheimer's: Study

The prevalent infection can trigger indigestion, gastritis, ulcers, and even stomach cancer

Stomach bug may increase risk of Alzheimer's: Study

A common gut bacteria found in two-thirds of the world's population may be linked to an increased risk of Alzheimer's disease, a new study has found.

The study, published in Alzheimer's & Dementia: The Journal of the Alzheimer's Association, investigated whether a clinically apparent Helicobacter pylori (H pylori) infection increased the risk of Alzheimer's disease in people aged 50 and older.


The prevalent infection can trigger indigestion, gastritis, ulcers, and even stomach cancer.

A team of McGill University researchers analysed the health data of over 4 million people in the UK aged 50 and above between 1988 and 2019.

It found that people with symptomatic H. pylori infection had an 11 per cent higher risk of developing Alzheimer's disease, the most common type of dementia.

While the cause of Alzheimer's disease is multifaceted, the findings build upon a growing body of evidence on the potential role of infections, particularly H Pylori, in its development.

The study opens avenues for future research, particularly exploring whether eradicating this bacterium could effectively prevent Alzheimer's disease in some people.

Alzheimer's disease affects millions of people globally, with numbers expected to rise sharply as demographics shift, say researchers.

"Given the global ageing population, dementia numbers are expected to triple in the next 40 years. However, there remains a lack of effective treatment options for this disease," said Dr Paul Brassard, the study's senior author and a Professor in McGill's Department of Medicine.

"We hope the findings from this investigation will provide insight on the potential role of H pylori in dementia in order to inform the development of prevention strategies, such as individualised eradication programmes, to reduce infections at the population level," said Dr Brassard, a public health and preventive medicine physician at the McGill University Health Centre.

(ANI)

More For You

Minorities in England face 'lower prescribing rates for diabetes tech'

The disparity is particularly concerning as approximately 5.8 m people across the UK live with diabetes

iStock

Minorities in England face 'lower prescribing rates for diabetes tech'

Highlights

  • Ethnic minorities are less likely to receive continuous glucose monitors despite having higher diabetes rates.
  • People from minority backgrounds make up 17.5 per cent of populations in areas with below-average device prescribing.
  • Ethnicity and deprivation account for up to 77 per cent of variance in diabetes technology prescribing.

People from ethnic minority backgrounds in England have significantly less access to vital diabetes technology, despite being at greater risk of developing the condition, according to groundbreaking research.

The study, published in Diabetic Medicine, reveals that black and south Asian communities face significantly lower prescribing rates for continuous glucose monitors (CGMs) – devices that help people manage their blood glucose levels more effectively than traditional finger-prick tests.

Keep ReadingShow less